ClearPoint Neuro (CLPT) Q2 2026 earnings — TrendMatrix coverage
MISS · WIDER LOSS-32.6% vs estimateEPS -$0.38 vs -$0.29 estVerdict Sell → Hold
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Event detail · Q2 2026
Key numbers
- Adjusted EPS
- -$0.38
- Estimate
- -$0.29
- Surprise
- -32.6%
- Revenue (period 2026-06-30)
- $10.9M
- Score at report (before → after)
- 5.2 → 5.4/10
Revenue source: xbrl.
Report record · Q2 2026
How the report landed
ClearPoint Neuro (CLPT) reported a wider loss than forecast — adjusted EPS of -$0.38 against the -$0.29 estimate (a 32.6% shortfall). TrendMatrix's engine moved from Sell (5.2/10) to Hold at 5.4/10 after the report — the engine's score rose despite the miss.